Enovis Corp
ENOV
Market Cap$2.87B
Close$
$-7.89
115.1% downside
Current Fair Value
115.1% downsideOvervalued by 115.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.87 Billion |
|---|---|
| Enterprise Value | $4.15 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.5 |
| Beta | 1.16 |
| Outstanding Shares | 54,850,906 |
| Avg 30 Day Volume | 639,840 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -35.1 |
|---|---|
| PEG | -16.85 |
| Price to Sales | 1.59 |
| Price to Book Ratio | 0.87 |
| Enterprise Value to Revenue | 2.28 |
| Enterprise Value to EBIT | -86.14 |
| Enterprise Value to Net Income | -51 |
| Total Debt to Enterprise | 0.32 |
| Debt to Equity | 0.4 |
Revenue Sources
No data
ESG Score
No data
About Enovis Corp
15,400 employees
CEO: Matthew Trerotola Colfax Corporation is a leading diversified technology company that provides specialty medical technologies and fabrication technology products and services to customers around the world, principally under the DJO and ESAB brands. Colfax...